BSECompany Update5d ago · 5 Aug 2026, 10:45 pm
Press Release for the Quarter ended June 30, 2026
Godavari Biorefineries Ltd · 544279
✦ AI SummaryResults
Godavari Biorefineries Ltd reported Q1 FY27 results, with revenue of ₹559.9 Cr, EBITDA of ₹2.6 Cr, and PAT of ₹(19.3) Cr. The company's Bio-based Chemicals business delivered strong revenue growth, healthy margin expansion, and improved profitability. Godavari Biorefineries also commissioned a 200 KLPD grain-based distillery, increasing its total ethanol capacity to 800 KLPD.
Analysis Scores
Earnings Impact4/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Godavari Biorefineries Ltd - 544279 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Attachments (1)
📄pdf
Download →
a83d67cf-1632-461b-a39a-d6594df8f123.pdf
View document text
Dated: August 05, 2026
The Manager The Manager
Listing Department Listing Department
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Tower,
Bandra Kurla Complex, Bandra (E), Dalal Street
Mumbai – 400 051 Mumbai-400001
Script Symbol: GODAVARIB Script Code:544279
Dear Sir / Madam,
Sub: Submission of Press Release on unaudited financial results for the Quarter Ended June 30, 2026
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015, please find enclosed herewith the Press Release being issued by the Company with respect to the
Unaudited Financial Results for the quarter ended June 30, 2026, as approved by the Board of Directors at
its meeting held today.
The aforesaid Press Release is also being made available on the website of the Company.
Kindly take the same on record
Thanking you,
Yours faithfully
For Godavari Biorefineries Limited
Manoj Jain
Company Secretary & Compliance O(cid:431)icer
Membership No. F-7998
Godavari Biorefineries Ltd.
Investor Release
Godavari Biorefineries Limited Reports Q1 FY27 Results
Resilient revenue growth amid industry headwinds
Mumbai, 05th August 2026 – Godavari Biorefineries Ltd., one of the largest producers of ethanol and
a pioneer in manufacturing bio-based specialty chemicals in India, announced its Financial Results for
the quarter ended on June30, 2026.
Q1 FY27 Key Snapshot
Bio-based Financial Ethanol Drug Discovery
Chemicals Strength
53% ₹13.9 Cr 200 KLPD Japanese Patent
EBITDA Growth YoY Finance costs Grain-based distillery Granted for Novel
commissioned Anti-cancer Molecule
9.0% YoY
11.4% 9.0% YoY 800 KLPD CDSCO Application
EBITDA Margin (₹15.3 crore in Q1 TotalCapacity Filed for Preliminary
vs 8.9% in Q1 FY26 FY26) Efficacy Trials for our
lead novel anti-cancer
molecule
Q1 FY27 Financial Performance (Consolidated)
TOTAL INCOME EBITDA* PAT
Rs. 559.9 Cr Rs. 2.6 Cr Rs. (19.3) Cr
Particulars (Rs. Cr) Q1 FY27 Q1 FY26 Q4 FY26 FY26
Total Income 559.9 534.0 570.0 2,000.2
EBITDA^ 2.6 6.5 92.1 139.3
PAT (19.3) (16.0) 52.9 3.5
* EBIDTA Includes Other Income
Godavari Biorefineries Ltd.
Investor Release
Segment Revenue Mix
Revenue from Operations Revenue from Operations
Rs. 557.9 Crores Rs. 533.2Crores
2% 2%
28% 33%
Q1 FY27 Q1 FY26
30% 26%
Sugar & Cogeneration Bio-Based Chemicals Ethanol Unallocated
Commenting on the Results, Shri Samir Somaiya, CMD said,
“Q1 FY27 marked an important quarter in strengthening Godavari Biorefineries' integrated
platform through strategic execution and operational milestones. During the quarter, we
successfully commissioned our 200 KLPD grain-based distillery at Sameerwadi, increasing our total
ethanol capacity to 800 KLPD and significantly enhancing our feedstock flexibility. This investment
strengthens our ability to optimize operations across varying market conditions while creating a
more resilient and future-ready ethanol business.
Our Bio-based Chemicals business delivered another strong quarter, with robust revenue growth,
healthy margin expansion and improved profitability, reflecting the benefits of our debottlenecking
initiatives and continued focus on higher-value specialty products. During the quarter, we also
secured an Indian patent for a cost-effective process to manufacture branched alcohols, reflecting
our continued focus on developing efficient and differentiated technologies.
Further advancing our innovation pipeline, we filed with the CDSCO to initiate preliminary efficacy
trials for our lead anti-cancer molecule targeting Triple Negative Breast Cancer, with trials expected
to commence from Q3 FY27, subject to regulatory approvals. This marks a significant milestone in
translating our R&D efforts into potential clinical applications.
As we look ahead, our strategic priorities remain centered on expanding our high-value Bio-based
Chemicals portfolio, strengthening strategic partnerships and commercialising innovation-led
products. We are equally focused on enhancing ethanol fungibility to capitalise on India's evolving
biofuel landscape, alongside sustained efforts in R&D and product innovation. These initiatives,
supported by our integrated bio-refinery platform, position us well to deliver sustainable long-term
growth and value creation.”
Godavari Biorefineries Ltd.
Investor Release
About Godavari Biorefineries Ltd
Godavari Biorefineries Ltd is one of the largest producers of ethanol and a pioneer in manufacturing bio-
based specialty chemicals in India. It’s diversified product portfolio comprises bio-based chemicals, sugar,
rectified spirits, ethanol, other grades of alcohol and power. It is the only company in India to have such a
vast portfolio of bio-based products.
Investor Relations: MUFG Intime India Pvt.
Company
Ltd.
Name: Mr. Ashish Sinha – AGM IR & Finance Name: Ms. Prachi Ambre / Mr. Irfan Raeen
Email: prachi.ambre@in.mpms.mufg.com /
Email: investorrelations@somaiya.com
irfan.raeen@in.mpms.mufg.com
Link
CIN: L67120MH1956PLC009707 Meeting Request Link
https://godavaribiorefineries.com/ Website: https://in.mpms.mufg.com/
Safe Harbor
Anyforward-lookingstatementsaboutexpectedfutureevents,financialandoperatingresultsoftheCompanyare
based on certain assumptions which the Company does not guarantee the fulfilment of. Past performance also
should not be simply extrapolatedinto the future.These statements are subjecttorisks anduncertainties.Actual
resultsmightdiffersubstantiallyormateriallyfromthoseexpressedorimplied.Importantdevelopmentsthatcould
affect the Company’s operations include a downtrend in the industry, global or domestic or both, significant
changes in political and economic environment in India or key markets abroad, tax laws, litigation, labour relations,
exchange rate fluctuations, technological changes, investment and business income, cash flow
projections,interest, and other costs. The Company does not undertake any obligation to update forward-looking
statements to reflect events or circumstances after the date thereof.